134 related articles for article (PubMed ID: 36528478)
1. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.
Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA
Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478
[TBL] [Abstract][Full Text] [Related]
2. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
4. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival.
Saunders EJ; Dadaev T; Brook MN; Wakerell S; Govindasami K; Rageevakumar R; Hussain N; Osborne A; Keating D; Lophatananon A; Muir KR; ; Darst BF; Conti DV; Haiman CA; Antoniou AC; Eeles RA; Kote-Jarai Z
Eur Urol Oncol; 2024 Apr; 7(2):248-257. PubMed ID: 38458890
[TBL] [Abstract][Full Text] [Related]
5. Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations.
Maier C; Herkommer K; Luedeke M; Rinckleb A; Schrader M; Vogel W
Prostate; 2014 Oct; 74(14):1444-51. PubMed ID: 25111659
[TBL] [Abstract][Full Text] [Related]
6. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
Randazzo M; Müller A; Carlsson S; Eberli D; Huber A; Grobholz R; Manka L; Mortezavi A; Sulser T; Recker F; Kwiatkowski M
BJU Int; 2016 Apr; 117(4):576-83. PubMed ID: 26332304
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to prostate cancer.
Benafif S; Eeles R
Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study.
Spain P; Carpenter WR; Talcott JA; Clark JA; Do YK; Hamilton RJ; Galanko JA; Jackman A; Godley PA
Cancer; 2008 Oct; 113(8):2180-7. PubMed ID: 18798229
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
[TBL] [Abstract][Full Text] [Related]
11. Does family history of prostate cancer affect outcomes following radiotherapy?
Bagshaw H; Ruth K; Horwitz EM; Chen DY; Buyyounouski MK
Radiother Oncol; 2014 Feb; 110(2):229-34. PubMed ID: 24560758
[TBL] [Abstract][Full Text] [Related]
12. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.
Clements MB; Vertosick EA; Guerrios-Rivera L; De Hoedt AM; Hernandez J; Liss MA; Leach RJ; Freedland SJ; Haese A; Montorsi F; Boorjian SA; Poyet C; Ankerst DP; Vickers AJ
Eur Urol; 2022 Aug; 82(2):163-169. PubMed ID: 34980493
[TBL] [Abstract][Full Text] [Related]
13. The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Shoaibi A; Rao GA; Cai B; Rawl J; Hébert JR
Ann Epidemiol; 2016 Jan; 26(1):36-42.e1-2. PubMed ID: 26611771
[TBL] [Abstract][Full Text] [Related]
14. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.
Agalliu I; Wang Z; Wang T; Dunn A; Parikh H; Myers T; Burk RD; Amundadottir L
PLoS One; 2013; 8(4):e60083. PubMed ID: 23573233
[TBL] [Abstract][Full Text] [Related]
15. Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy.
Grizzle WE; Kittles RA; Rais-Bahrami S; Shah E; Adams GW; DeGuenther MS; Kolettis PN; Nix JW; Bryant JE; Chinsky R; Kearns JE; Dehimer K; Terrin N; Chang H; Gaston SM
Cancer Med; 2019 Nov; 8(16):6915-6922. PubMed ID: 31568648
[TBL] [Abstract][Full Text] [Related]
16. Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy.
Westerman ME; Gershman B; Karnes RJ; Thompson RH; Rangel L; Boorjian SA
World J Urol; 2016 Aug; 34(8):1115-22. PubMed ID: 26658661
[TBL] [Abstract][Full Text] [Related]
17. Family history is significantly associated with prostate cancer and its early onset in Chinese population.
Xu Y; Huang D; Wu Y; Ye D; Zhang N; Gao Y; Xu D; Na R; Xu J
Prostate; 2019 Nov; 79(15):1762-1766. PubMed ID: 31497879
[TBL] [Abstract][Full Text] [Related]
18. Family history in the Finnish Prostate Cancer Screening Trial.
Saarimäki L; Tammela TL; Määttänen L; Taari K; Kujala PM; Raitanen J; Auvinen A
Int J Cancer; 2015 May; 136(9):2172-7. PubMed ID: 25274038
[TBL] [Abstract][Full Text] [Related]
19. Association between family history of prostate cancer and positive biopsies in a Brazilian screening program.
Muller RL; Faria EF; Carvalhal GF; Reis RB; Mauad EC; Carvalho AL; Freedland SJ
World J Urol; 2013 Oct; 31(5):1273-8. PubMed ID: 22820620
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Clinical and Genetic Analysis of
Kirchner K; Gamulin M; Kulis T; Sievers B; Kastelan Z; Lessel D
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
